Patents by Inventor Kor Seng @ Chan Kok Seng TAN

Kor Seng @ Chan Kok Seng TAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230364116
    Abstract: An aqueous parenteral nutrition composition includes deoxycholic acid, cytidine diphosphate-choline and choline alfoscerate. The parenteral nutrition further includes 4.5-5.5% (w/v) phosphatidylcholine, in which combination of the phosphatidycholine with cytidine diphosphate-choline and choline alfoscerate increases choline bioavailability for immediate onset of action.
    Type: Application
    Filed: December 31, 2020
    Publication date: November 16, 2023
    Inventors: Kor Seng @ Chan Kok Seng TAN, Bi Fah WONG, Joanamarie R KUYONG
  • Patent number: 11097004
    Abstract: The present invention provides a serum and its blood components isolated from blood, wherein the blood is drawn from body of a patient, and a normal saline solution mixed with the serum and its blood components, characterized in that a Reagent A having at least one type of adjuvant, and a Reagent B having at least one type of transfer factor peptide and a buffered saline, and Reagent C having an alpha lipoic acid are added to the mixture of the serum and its blood components and the normal saline solution, such that the composition enhances cell-mediated immunity and T suppressor cells in the patient to act against autoimmune disease. The present invention also provides a method for producing such composition for immunotherapy thereof.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: August 24, 2021
    Assignee: BADEN R&D LABORATORIES GMBH
    Inventors: Kor Seng @ Chan Kok Seng Tan, Bi Fah Wong
  • Publication number: 20210038712
    Abstract: The present invention provides a serum and its blood components isolated from blood, wherein the blood is drawn from body of a patient, and a normal saline solution mixed with the serum and its blood components, characterized in that a Reagent A having at least one type of adjuvant, and a Reagent B having at least one type of transfer factor peptide and a buffered saline, and Reagent C having an alpha lipoic acid are added to the mixture of the serum and its blood components and the normal saline solution, such that the composition enhances cell-mediated immunity and T suppressor cells in the patient to act against autoimmune disease. The present invention also provides a method for producing such composition for immunotherapy thereof.
    Type: Application
    Filed: August 20, 2019
    Publication date: February 11, 2021
    Inventors: Kor Seng @ Chan Kok Seng TAN, Bi Fah WONG